EXELDERM (sulconazole nitrate)
Tinea pedis, cruris, and corporis (fungal infections)
ApprovedActive
Key Facts
Indication
Tinea pedis, cruris, and corporis (fungal infections)
Phase
Approved
Status
Active
Company
About Medimetriks Pharmaceuticals
Medimetriks Pharmaceuticals is a private, commercial-stage biopharmaceutical company dedicated to the dermatology sector. The company has successfully transitioned from development to commercialization, bringing approved products to market for conditions like fungal infections and acne. Its strategy involves identifying, developing, and marketing both novel and established dermatological treatments, leveraging a specialized commercial footprint. As a focused dermatology player, Medimetriks operates in a stable and growing market with persistent patient demand.
View full company profile